Events
Actor, director and advocate Rob Reiner opened the third day of the 2018 BIO International Convention.
Appaloosa Management’s David Tepper and Senator Investment Group’s Douglas Silverman sent a letter to Allergan’s board of directors yesterday asking—or demanding—that the company split the roles of chief executive officer and chairman.
Robin Roberts, ABC’s Good Morning America journalist and anchor, kicked off the 2018 BIO International Convention in Boston with her keynote address.
Portola Pharmaceuticals’ chief executive officer, William Lis, plans to retire as both chief executive and board member.
Horizon Pharma and the National Organization for Rare Disorders (NORD) launched a new campaign today that recognizes innovation in rare disease therapeutics since the passing of the Orphan Drug Act in 1983.
The 2018 BIO International Convention will be officially running from June 4 through June 7 and is celebrating 25 years of innovation.
Shares of CRISPR Therapeutics plunged dramatically Wednesday after the U.S. Food and Drug Administration placed a clinical hold on a planned sickle cell disease treatment the company was in the process of developing with Vertex Pharmaceuticals.
With the ever-increasing concerns of the opioid crisis facing the United States, the U.S. Food and Drug Administration has launched an “innovation challenge” to spur on the development of medical devices that can combat the crisis and help prevent and treat opioid use disorder.
Allergan will sell off two non-core businesses following a strategic review of the company’s assets, according to multiple reports.
Despite everyone’s apparent addiction to technology—just note the use of smartphones or the way people line up to buy the newest iteration of Apple’s iPhone—there is a definite vein of anti-science and technophobia running through the American public.
PRESS RELEASES